CN1059335C - Oral liquid for enriching blood and clearing numbness - Google Patents
Oral liquid for enriching blood and clearing numbness Download PDFInfo
- Publication number
- CN1059335C CN1059335C CN 96109840 CN96109840A CN1059335C CN 1059335 C CN1059335 C CN 1059335C CN 96109840 CN96109840 CN 96109840 CN 96109840 A CN96109840 A CN 96109840A CN 1059335 C CN1059335 C CN 1059335C
- Authority
- CN
- China
- Prior art keywords
- numbness
- radix
- clearing
- nourishing
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention provides an oral liquid for nourishing the blood and clearing numbness, which is a water extraction liquid prepared from the following eight Chinese herbal medicines: angelica, white peony alba, hemlock parsley, rehmannia root, ledebouriella root, mulberry twig, milkvetch root and cornus. The oral liquid with the efficacy of regulating vital energy, nourishing the blood, nourishing the liver and kidney, dredging the channel, dispelling wind, relieving pain, etc. is suitable for the treatment of rheumatoid arthritis, the paralysis of the limbs, arthroncus, arthralgia, periarthritis of shoulder, etc., and can prevent and treat serious arthralgia diseases, such as deformed joints of the whole body, osteoporosis, kneecap softening, ankylosing spondylitis, etc. The present invention with the advantages of reasonable synergy, convenient administration and obvious and stable therapeutic effect can treat both manifestation and root cause of disease, and is a novel Chinese patent medicine for nourishing blood and clearing numbness.
Description
The present invention relates to the rheumatoid oral liquid for enriching blood and clearing numbness of a kind of treatment, belong to the Chinese patent drug technical field.
Rheumatoid disease is a kind of chronic, systemic disease of outbreak repeatedly, and potential causes heart change, directly affects people's physical and mental health, needs prevention in time and treatment.At present, be used for the treatment of that rheumatoid Chinese patent drug mainly contains TONGBI PIAN, the numbness that disappears sheet, WANGBI CHONGJI, its main component is the Radix Rehmanniae, Radix Angelicae Sinensis, Herba Epimedii, Radix Angelicae Pubescentis, Semen Strychni (processed), Squama Manis, Flos Carthami, Radix Ginseng, Agkistrodon, Rhizoma Gastrodiae, Radix Aconiti Preparata, Spina Gleditsiae, Scorpio, Pheretima etc.Because the pathological characters of human body is different, the rheumatoid cause of disease is complicated, and existing Chinese patent medicine has cures mainly rheumatoid arthritis, only control its mark, and curative effect is shorter, easily causes disease relapse.
The present invention's purpose provides a kind of oral liquid for enriching blood and clearing numbness, with reach treatment must aim at the pathogenesis of disease, curative effect is obvious, long-term consolidates, the cure rate height, can Comprehensive Treatment and the multiple rheumatoid disease of prevention.
For achieving the above object, the solution that the present invention adopts is: discuss the theory of controlling according to China's differential diagnosis in tcm, at rheumatoid disease by QI and blood two lose, the liver failing to be nourished and can not make the defeated meridians that are distributed in of blood, the exterior deficiency spontaneous perspiration then occurs, aversion to wind, limbs are unsuccessful, the main cause of arthritis and heart change.In line with treatment must aim at the pathogenesis of disease, the principle of suiting the remedy to the case, employing by Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Chuanxiong, the Radix Rehmanniae, Radix Saposhnikoviae, Ramulus Mori, the Radix Astragali and Fructus Corni totally 8 the flavor pure Chinese herbal medicine, be by weight ratio: the aqueous extract that Radix Angelicae Sinensis 6-20, Radix Paeoniae Alba 15-35, Rhizoma Chuanxiong 6-15, Radix Rehmanniae 10-30, Radix Saposhnikoviae 5-15, Ramulus Mori 15-35, Radix Astragali 8-25, Fructus Corni 6-20 make.
The preparation method of oral liquid for enriching blood and clearing numbness of the present invention is: 8 flavor Chinese herbal medicine of above-mentioned prescription are equipped with by weight part respectively, clean with warm water earlier, put into container, add entry 200-600 by the weight proportion that adds Chinese herbal medicine, decoct and produce medicinal liquid, after filtration, after the clarification, add former crystal sugar 6-15 again by the weight proportion that adds Chinese herbal medicine again, to make by adding Chinese herbal medicine and its weight of water weight proportion be the finished product medicinal liquid of 60-200 through concentrating; At last, carry out packing, sealing, packing, be oral liquid for enriching blood and clearing numbness of the present invention.
The present invention is according to the Chinese elite Chinese medical theory, the rheumatismal pathological research of association class, and through treating rheumatoid clinical practice, the selected pure Chinese herbal medicine water extraction of 8 flavors that adopted is made.It has compensate qi and blood, nourishing the liver and kidney, the effects such as the meridian dredging, wind-expelling pain-stopping of relaxing.Be applicable to treatment rheumatoid arthritis, unsuccessful, the joint swelling and pain of limbs, diseases such as scapulohumeral periarthritis, and can prophylactic treatment the generation of serious numbness diseases such as whole body joint deformity, cervical spondylosis, prolapse of lumbar intervertebral disc, osteoporosis, patella osteomalacia, ankylosing spondylitis.Show that through the numerical example clinic trial total effective rate reaches more than 95%.Its flavour of a drug are few, and compatibility is reasonable, taking convenience, and the energy treating both the principal and secondary aspects of a disease, curative effect is obviously consolidated, and is that a kind of enriching blood and clearing numbness is treated rheumatoid new Chinese patent drug.
The embodiment of the invention:
Chinese herbal medicine title prescription 1 prescription 2 prescriptions 3
Radix Angelicae Sinensis 15g 10g 15g
Radix Paeoniae Alba 30g 25g 20g
Rhizoma Chuanxiong 12g 8g 12g
Radix Rehmanniae 25g 20g 25g
Radix Saposhnikoviae 10g 10g 8g
Ramulus Mori 30g 25g 20g
Radix Astragali 20g 15g 20g
Fructus Corni 10g 15g 10g
Preparation method: as being equipped with, clean with 10-15 ℃ of warm water earlier, put into container, add entry 450g, after decocting, after filtration, after the clarification, add former crystal sugar 10g again, concentrate and make 100g finished product medicinal liquid by the pharmaceutical quantities of above-mentioned prescription 1; Carry out packing, sealing, packing and be this oral liquid for enriching blood and clearing numbness product.
Claims (1)
1, a kind of oral liquid for enriching blood and clearing numbness that contains Radix Angelicae Sinensis, the Radix Rehmanniae, it is characterized in that this oral liquid also comprises the Radix Paeoniae Alba, Rhizoma Chuanxiong, Radix Saposhnikoviae, Ramulus Mori, the Radix Astragali and the Fructus Corni pure Chinese herbal medicine of totally 8 flavors, is: the aqueous extract that Radix Angelicae Sinensis 6-20, Radix Paeoniae Alba 15-35, Rhizoma Chuanxiong 6-15, Radix Rehmanniae 10-30, Radix Saposhnikoviae 5-15, Ramulus Mori 15-35, Radix Astragali 8-25, Fructus Corni 6-20 make by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96109840 CN1059335C (en) | 1996-09-20 | 1996-09-20 | Oral liquid for enriching blood and clearing numbness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96109840 CN1059335C (en) | 1996-09-20 | 1996-09-20 | Oral liquid for enriching blood and clearing numbness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1148973A CN1148973A (en) | 1997-05-07 |
| CN1059335C true CN1059335C (en) | 2000-12-13 |
Family
ID=5120654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96109840 Expired - Fee Related CN1059335C (en) | 1996-09-20 | 1996-09-20 | Oral liquid for enriching blood and clearing numbness |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059335C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104997838A (en) * | 2015-07-31 | 2015-10-28 | 赵妙元 | Rheumatism medical wine |
| CN105396091A (en) * | 2015-11-25 | 2016-03-16 | 王雅芳 | Traditional Chinese medicine formula composition for treating scapulohumeral periarthritis |
| CN105963626A (en) * | 2016-03-03 | 2016-09-28 | 亳州市益众堂保健食品有限公司 | Pawpaw wine for rheumatism and preparing method thereof |
| CN105998372A (en) * | 2016-07-22 | 2016-10-12 | 刘德喜 | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method of traditional Chinese medicine composition for treating cervical spondylosis |
-
1996
- 1996-09-20 CN CN 96109840 patent/CN1059335C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1148973A (en) | 1997-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393879B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN102327592A (en) | Preparation method of traditional Chinese medicine lotion for curing malnourished bedsore | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN100473411C (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
| CN103301440A (en) | Chinese medicine capable of warming Yang and tonifying kidneys | |
| CN104771606A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN102698093B (en) | Chinese medicinal composition for treating liver and kidney deficiency type hypertension and preparation method thereof | |
| CN1059335C (en) | Oral liquid for enriching blood and clearing numbness | |
| CN103239582B (en) | Chinese medicinal preparation for treating migraine | |
| CN106214986A (en) | A kind of Chinese medicine decoction treating cardiovascular and cerebrovascular disease | |
| CN102416145A (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
| CN1365819A (en) | Medicine for treating apoplexy | |
| CN104623536A (en) | Chinese medicinal combination for treating insomnia | |
| CN103638426A (en) | Traditional Chinese medicine mixture used for treating kidney deficiency, impotence and premature ejaculation | |
| CN102406904A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102600414B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN104784458A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
| CN1039674C (en) | Medicine "Yuntongling" for treating dizziness and headache | |
| CN104587131A (en) | Traditional Chinese medicinal composition for treating delayed menorrhea | |
| CN1148202C (en) | Medicine for eliminating bursa | |
| CN1056242A (en) | Consolidate the compound method of near-sighted refinery liquor | |
| CN102349983A (en) | Traditional Chinese medicine composition for treating ischemic apoplexia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |